about
MicroRNAs are involved in the self-renewal and differentiation of cancer stem cellsMiR-200, a new star miRNA in human cancerPanepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancerMulti-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatinSystematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.Normalizing bead-based microRNA expression data: a measurement error model-based approach.MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.Testing for differentially-expressed microRNAs with errors-in-variables nonparametric regression.Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityEntecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis.MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit.Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAsA novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activityLarge isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets.Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.MicroRNAs and anticancer drugs.SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro.Aquaporins mediate the chemoresistance of human melanoma cells to arsenite.Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip).Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions.miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.A personalized microRNA microarray normalization method using a logistic regression model.MicroRNA, epigenetic machinery and lung cancer.Esophageal cancer in Chinese population: no polymorphism in codon 149 of P21(Waf1/Cip1) cyclin dependent kinase geneAssociation of insulin-like growth factor binding protein-3 expression with melanoma progressionMicroRNA provides insight into understanding esophageal cancer
P50
Q26828793-81A5EEA8-DABF-43A5-B971-7AF23774FC97Q27004023-7BCF8041-56C7-441D-8888-590505B6C288Q28387216-8E08FE47-D6E8-4850-9AB3-DDDE84DE93A5Q33238496-142834FE-4A38-4E3B-A738-D6AEFB2FE672Q33396223-6F93D6EB-C244-4B8C-BC48-72F2DEB3E91EQ33828375-FA0C69E2-A63E-495F-8846-172EDC2ED760Q33875034-F12F89DD-ADF0-49CE-8B3F-3567DCB93667Q33967256-06E87155-C6DB-4A61-9BE2-0CEF57C56E5CQ34289012-77FA1AEA-2602-4658-AB20-A873F5DBFD84Q34416260-13520765-FC43-44F2-A585-9B5519E61287Q34864684-88746B18-9111-42FA-B006-4842F5D8C58FQ35754703-C79707CB-9ED8-4A15-89FB-B84D9888BEAEQ36024500-B52591AD-0EBA-45AC-879F-087564B9D76FQ36537864-F865CE9B-5506-49B4-8855-D3C9A329AC29Q36678643-8907C618-7A1C-41EA-8F46-F5932511E7D6Q37179767-840FE702-144B-4EA8-B59E-36A64DF4D58FQ37514369-82E3A801-02CD-49C3-9943-742359B49B2BQ38184857-3E70113F-AE37-4E30-B7CB-766F208DE1D2Q38948469-869D0FF1-3015-4247-9D1B-69BB9B8FDFF8Q39435097-E44E7156-BF36-4B70-B05D-878D242AF29CQ39745242-28A34A6B-9BC6-4A72-9010-3FB919C7B79BQ39844056-9D96A8A7-8933-4C3D-AE83-D1934F0079AEQ39862394-A0805E09-A62D-4BBB-9BA4-744DCE79E9CDQ40538258-40769427-355B-4339-B6FF-A846C3DA0FDDQ41895223-9B402A17-2371-4035-A43D-F9014D1BD8CEQ42009448-26EDFA65-22BC-4108-B959-FDE8B640B51DQ43521983-D65F114E-58FF-4D28-8607-D958D7D2F573Q51711929-9A51F2DA-4B47-4B7D-A119-2953746F2B93Q78427338-8CE873BC-ACE6-4866-8D77-CE32E0A15428Q79436245-46B33741-3F2F-473C-BF70-743BF117BC10Q88580974-7ED5F7BD-73CC-411F-B20F-74DDF79E5079
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yaguang Xi
@ast
Yaguang Xi
@en
Yaguang Xi
@es
Yaguang Xi
@nl
Yaguang Xi
@sl
type
label
Yaguang Xi
@ast
Yaguang Xi
@en
Yaguang Xi
@es
Yaguang Xi
@nl
Yaguang Xi
@sl
prefLabel
Yaguang Xi
@ast
Yaguang Xi
@en
Yaguang Xi
@es
Yaguang Xi
@nl
Yaguang Xi
@sl
P106
P1153
13105421500
P31
P496
0000-0003-3681-9352